VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

42 hedge funds and large institutions have $5.61M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

44% less capital invested

Capital invested by funds: $10.1M → $5.61M (-$4.47M)

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$96.1K
2
+$65.2K
3
+$23.6K
4
Squarepoint
Squarepoint
New York
+$20.6K
5
Renaissance Technologies
Renaissance Technologies
New York
+$17.5K

Top Sellers

1
-$77K
2
-$55K
3
-$38K
4
MCM
MAI Capital Management
Ohio
-$24.1K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6.7K
27
$6K
28
$5.86K
29
$4.6K
30
$4.28K
31
$4.15K
32
$2.11K
33
$2K
34
$1.71K
35
$411
36
$217
37
$114
38
$8
39
$5
40
$3
41
$2
42
$1
43
–
44
–
45
–
46
–
47
–
1
2